Orally administered TGF-β is biologically active in the intestinal mucosa and enhances oral tolerance
- 31 October 2007
- journal article
- Published by Elsevier BV in Journal of Allergy and Clinical Immunology
- Vol. 120 (4), 916-923
- https://doi.org/10.1016/j.jaci.2007.05.023
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
- Ministry of Health, Labour and Welfare
This publication has 24 references indexed in Scilit:
- Bioluminescence imaging of Smad signaling in living mice shows correlation with excitotoxic neurodegenerationProceedings of the National Academy of Sciences of the United States of America, 2006
- Oral tolerance and allergic responses to food proteinsCurrent Opinion in Allergy and Clinical Immunology, 2006
- Transforming growth factor‐β1 and interleukin‐10 in breast milk and development of atopic diseases in infantsClinical and Experimental Allergy, 2006
- Suppression of serum IgE response and systemic anaphylaxis in a food allergy model by orally administered high-dose TGF-βInternational Immunology, 2005
- TGF-β in human milk is associated with wheeze in infancyJournal of Allergy and Clinical Immunology, 2003
- Signal Transduction by the TGF-β SuperfamilyScience, 2002
- Transforming growth factor-β in breast milk: A potential regulator of atopic disease at an early ageJournal of Allergy and Clinical Immunology, 1999
- REGULATION OF IMMUNE RESPONSES BY TGF-βAnnual Review of Immunology, 1998
- Transforming growth factor-beta (TGF-β) in human milkClinical and Experimental Immunology, 1993
- The Transforming Growth Factor-beta FamilyAnnual Review of Cell Biology, 1990